MAIA Biotechnology

MAIANYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$63.903 M

$1.04 -9.21%

Close of 6 Nov 2026

As of 6 Nov 2026, MAIA Biotechnology (MAIA) has a market capitalization of $63.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

60,825,844

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#312LifevantageLFVN$66.0M
#313Stablecoin DevelopmentSDEV$65.7M
#314MAIA BiotechnologyMAIA$63.9M
#315CingulateCING$61.4M
#316Fortress BiotechFBIO$61.4M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of MAIA Biotechnology, worth $51.9K. Grants and option exercises are excluded.

Ramiro Guerrero$49.5K
37,595 shares at $1.32 on 10 Sept 2026 · filed 14 Sept 2026
Ramiro Guerrero$2.39K
1,794 shares at $1.33 on 24 Aug 2026 · filed 26 Aug 2026

What if MAIA Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$457,336.96

Per share 441,871× higher

Bitcoin $1.53T

$24,745.71

Per share 23,909× higher

Apple $5.02T

$81,237.84

Per share 78,491× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for MAIA Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.